Imaging pH and metastasis

被引:213
作者
Hashim, Arig Ibrahim [1 ]
Zhang, Xiaomeng [1 ]
Wojtkowiak, Jonathan W. [1 ]
Martinez, Gary V. [1 ]
Gillies, Robert J. [1 ]
机构
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Expt Imaging Program,Dept Imaging Res, Tampa, FL 33612 USA
关键词
tumor pH; metastasis; tumor microenvironment; MAGNETIC-RESONANCE-SPECTROSCOPY; EPITHELIAL-MESENCHYMAL TRANSITION; HIGH LACTATE LEVELS; EXTRACELLULAR PH; IN-VIVO; INTRACELLULAR PH; PROTON-EXCHANGE; TUMOR ACIDITY; LACTIC-ACID; CONTRAST AGENTS;
D O I
10.1002/nbm.1644
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Metastasis is a multistep process that culminates in the spread of cells from a primary tumor to a distant site or organs. For tumor cells to be able to metastasize, they have to locally invade through basement membrane into the lymphatic and the blood vasculatures. Eventually they extravasate from the blood and colonize in the secondary organ. This process involves multiple interactions between the tumor cells and their microenvironments. The microenvironment surrounding tumors has a significant impact on tumor development and progression. A key factor in the microenvironment is an acidic pH. The extracellular pH of solid tumors is more acidic in comparison to normal tissue as a consequence of high glycolysis and poor perfusion. It plays an important role in almost all steps of metastasis. The past decades have seen development of technologies to non-invasively measure intra- and/or extracellular pH. Most successful measurements are MR-based, and sensitivity and accuracy have dramatically improved. Quantitatively imaging the distribution of acidity helps us understand the role of the tumor microenvironment in cancer progression. The present review discusses different MR methods in measuring tumor pH along with emphasizing the importance of extracelluar tumor low pH on different steps of metastasis; more specifically focusing on epithelial-to-mesenchymal transition (EMT), and anti cancer immunity. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:582 / 591
页数:10
相关论文
共 82 条
[1]   Differential cadherin expression: Potential markers for epithelial to mesenchymal transformation during tumor progression [J].
Agiostratidou, Georgia ;
Hulit, James ;
Phillips, Greg R. ;
Hazan, Rachel B. .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2007, 12 (2-3) :127-133
[2]   Paramagnetic lanthanide(III) complexes as pH-sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications [J].
Aime, S ;
Barge, A ;
Delli Castelli, D ;
Fedeli, F ;
Mortillaro, A ;
Nielsen, FU ;
Terreno, E .
MAGNETIC RESONANCE IN MEDICINE, 2002, 47 (04) :639-648
[3]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[4]   THE SEPARATION OF PHOSPHOCREATINE FROM CREATINE, AND PH DETERMINATION IN FROG-MUSCLE BY NATURAL ABUNDANCE C-13-NMR [J].
ARUS, C ;
CHANG, YC ;
BARANY, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 844 (01) :91-93
[5]  
Beauregard DA, 1998, P 6 ANN M ISMRM SYDN, P53
[6]   Estimations of intra- and extracellular volume and pH by 31P magnetic resonance spectroscopy:: effect of therapy on RIF-1 tumours [J].
Bhujwalla, ZM ;
McCoy, CL ;
Glickson, JD ;
Gillies, RJ ;
Stubbs, M .
BRITISH JOURNAL OF CANCER, 1998, 78 (05) :606-611
[7]   Epithelial mesenchymal transition traits in human breast cancer cell lines [J].
Blick, T. ;
Widodo, E. ;
Hugo, H. ;
Waltham, M. ;
Lenburg, M. E. ;
Neve, R. M. ;
Thompson, E. W. .
CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 (06) :629-642
[8]   Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes [J].
Blum, Galia ;
von Degenfeld, Georges ;
Merchant, Milton J. ;
Blau, Helen M. ;
Bogyo, Matthew .
NATURE CHEMICAL BIOLOGY, 2007, 3 (10) :668-677
[9]  
Bosticardo M, 2001, EUR J IMMUNOL, V31, P2829, DOI 10.1002/1521-4141(200109)31:9<2829::AID-IMMU2829>3.0.CO
[10]  
2-U